1.0ICCChttps://italchamber.qc.ca/it/ICCChttps://italchamber.qc.ca/it/rich600338<blockquote class="wp-embedded-content" data-secret="CZ2JTNEgF2"><a href="https://italchamber.qc.ca/it/speakers/ettore-rizzo-co-founder-engenome/">Ettore Rizzo – Co-founder, enGenome</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://italchamber.qc.ca/it/speakers/ettore-rizzo-co-founder-engenome/embed/#?secret=CZ2JTNEgF2" width="600" height="338" title="“Ettore Rizzo – Co-founder, enGenome” — ICCC" data-secret="CZ2JTNEgF2" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://italchamber.qc.ca/wp-includes/js/wp-embed.min.js </script> https://italchamber.qc.ca/wp-content/uploads/2024/10/1.Rizzo_-768x742.png600580Ettore Rizzo is a co-founder of enGenome (www.engenome.com), a bioinformatics company that has developed a SaaS platform (eVai) that enables geneticists to detect pathogenic genomic variants with unprecedented accuracy and speed. By combining bioinformatics, AI and international guidelines, eVai accurately classifies and prioritizes every genomic variant of a patient, suggesting a list of possible related […]